Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 12, 2011, Pages 1587-1593

  Ramos, N L ^a,b   Dzung, D T N ^b,c   Stopsack, K ^b   Janko V ^d   Pourshafie, M R ^e   Katouli, M ^a   Brauner, A ^b  

^a UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HANOI MEDICAL UNIVERSITY   (Viet Nam)

^d Physics and Informatics   (Slovakia)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL ANTIGEN; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CELLULOSE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CHILD; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI INFECTION; FLU GENE; FLUACFT073 GENE; FLUBCFT073 GENE; HUMAN; IRAN; MULTIDRUG RESISTANCE; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SLOVAKIA; SURVIVAL TIME; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; VIET NAM;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENETIC VARIATION; HUMANS; INFANT; MALE; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 83655191834     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1264-4     Document Type: Article

References (33)

1. R Chakupurakal M Ahmed DN Sobithadevi S Chinnappan T Reynolds 2010 Urinary tract pathogens and resistance pattern J Clin Pathol 63 652 654 20501451 10.1136/jcp.2009.074617 1:STN:280:DC%2BC3cnjsl2luw%3D%3D
2. G Williams JC Craig 2009 Prevention of recurrent urinary tract infection in children Curr Opin Infect Dis 22 72 76 19532083 10.1097/QCO.0b013e328320a885
3. N Shaikh NE Morone JE Bost MH Farrell 2008 Prevalence of urinary tract infection in childhood Pediatr Infect Dis J 27 302 308 18316994 10.1097/INF.0b013e31815e4122 (Pubitemid 351483063)
4. S Leroy M Chalumeau T Ulinski F Dubos A Sergent-Alaoui V Merzoug H Ducou-le-Pointe G Audry D Gendrel A Bensman 2010 Impressive renal damage after acute pyelonephritis in a child Pediatr Nephrol 25 1365 1368 20157735 10.1007/s00467-010-1461-x
5. PH Conway A Cnaan T Zaoutis BV Henry RW Grunmeier R Keren 2007 Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials JAMA 298 179 186 17622599 10.1001/jama.298.2.179 1:CAS:528:DC%2BD2sXnslSjtbo%3D (Pubitemid 47057764)
6. JC Craig JM Simpson GJ Williams A Lowe GJ Reynolds SJ McTaggart EM Hodson JR Carapetis NE Cranswick G Smith LM Irwig PHY Caldwell S Hamilton LP Roy 2009 Antibiotic prophylaxis and recurrent urinary tract infection in children N Engl J Med 361 1748 1759 19864673 10.1056/NEJMoa0902295 1:CAS:528:DC%2BD1MXhtlajsLfI
7. M Bitsori S Maraki M Kalmanti E Galanakis 2009 Resistance against broad-spectrum β-lactams among uropathogens in children Pediatr Nephrol 24 2381 2386 19636594 10.1007/s00467-009-1255-1
8. F Catal N Bavbek O Bayrak M Karabel D Karabel E Odemis E Uz 2009 Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006 Int Urol Nephrol 41 953 957 18704743 10.1007/s11255-008-9445-5
9. C-H Cheng Y-K Tsau C-Y Kuo L-H Su T-Y Lin 2010 Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia Pediatr Infect Dis J 29 736 740 20661102 10.1097/INF.0b013e3181dab249
10. GC Ulett J Valle C Beloin O Sherlock J-M Ghigo MA Schembri 2007 Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract Infect Immun 75 3233 3244 17420234 10.1128/IAI.01952-06 1:CAS:528:DC%2BD2sXptV2ks7w%3D (Pubitemid 47040924)
11. P Lüthje A Brauner 2010 Ag43 promotes persistence of uropathogenic Escherichia coli isolates in the urinary tract J Clin Microbiol 48 2316 2317 20357219 10.1128/JCM.00611-10
12. Y Kai-Larsen P Lüthje M Chromek V Peters X Wang Å Holm L Kadas K-J Hedlund J Johansson MR Chapman SH Jacobson U Römling B Agerberth A Brauner 2010 Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37 PLoS Pathog 6 e1001010 20661475 10.1371/journal.ppat.1001010
13. NM Cooke SG Smith M Kelleher TR Rogers 2010 Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates J Clin Microbiol 48 1099 1104 20107091 10.1128/JCM.02017-09 1:CAS:528:DC%2BC3cXmt1KgtLo%3D
14. JR Johnson JJ Brown 1996 A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(α1-4)Gal-binding PapG adhesins of Escherichia coli J Infect Dis 173 920 926 8603972 10.1093/infdis/173.4.920 1:CAS:528:DyaK28XisVCitb8%3D (Pubitemid 26176016)
15. O Clermont S Bonacorsi E Bingen 2000 Rapid and simple determination of the Escherichia coli phylogenetic group Appl Environ Microbiol 66 10 4555 4558 11010916 10.1128/AEM.66.10.4555-4558.2000 1:CAS:528:DC%2BD3cXnt1Cls70%3D
16. C Restieri G Garriss M-C Locas CM Dozois 2007 Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains Appl Environ Microbiol 73 1553 1562 17220264 10.1128/AEM.01542-06 1:CAS:528:DC%2BD2sXjsVSksbg%3D (Pubitemid 46417880)
17. AJ Roche JP McFadden P Owen 2001 Antigen 43, the major phase-variable protein of the Escherichia coli outer membrane, can exist as a family of proteins encoded by multiple alleles Microbiology 147 161 169 11160810 1:CAS:528:DC%2BD3MXhtlWnu7w%3D (Pubitemid 32094319)
18. N van de Sande-Bruinsma H Grundmann D Verloo E Tiemersma J Monen H Goossens M Ferech Groups EARSSGaESoACP 2008 Antimicrobial drug use and resistance in Europe Emerg Infect Dis 14 1722 1730 18976555 10.3201/eid1411. 070467
19. Y Pan J Henderson H Britt 2006 Antibiotic prescribing in Australian general practice: how has it changed from 1990-91 to 2002-03 Respir Med 100 2004 2011 16616483 10.1016/j.rmed.2006.02.015 (Pubitemid 44490281)
20. S Mölstad M Erntell H Hanberger E Melander C Norman G Skoog CS Lundborg A Söderström E Torell O Cars 2008 Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme Lancet Infect Dis 8 125 132 18222163 10.1016/S1473-3099(08) 70017-3
21. H Mehrgan M Rahbar Z Arab-Halvaii 2010 High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran J Infect Dev Ctries 4 132 138 20351452 10.3855/jidc.488
22. DV Duong CW Binns TV Le 1997 Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam Trop Med Int Health 2 1133 1139 9438468 10.1046/j.1365-3156.1997.d01-213.x (Pubitemid 28036027)
23. RJ Gaspari E Dickson J Karlowsky G Doern 2006 Multidrug resistance in pediatric urinary tract infections Microb Drug Resist 12 126 129 16922629 10.1089/mdr.2006.12.126 1:CAS:528:DC%2BD28XntVWlt7w%3D (Pubitemid 44164263)
24. AS Bukh HC Schønheyder JMG Emmersen M Søgaard S Bastholm P Roslev 2009 Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark J Antimicrob Chemother 64 163 168 19429665 10.1093/jac/dkp156 1:CAS:528:DC%2BD1MXntlGgtrY%3D
25. JR Johnson MA Kuskowski A Gajewski DF Sahm JA Karlowsky 2004 Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001 J Infect Dis 190 1739 1744 15499527 10.1086/425018 1:CAS:528:DC%2BD2cXhtVKitb3J (Pubitemid 39487816)
26. H Narchi M Al-Hamdani 2010 Uropathogen resistance to antibiotic prophylaxis in urinary tract infections Microb Drug Resist 16 151 154 20370510 10.1089/mdr.2009.0115 1:CAS:528:DC%2BC3cXptFyrt7k%3D
27. AN Mabbett GC Ulett RE Watts JJ Tree M Totsika CL Ong JM Wood W Monaghan DF Looke GR Nimmo C Svanborg MA Schembri 2009 Virulence properties of asymptomatic bacteriuria Escherichia coli Int J Med Microbiol 299 1 53 63 18706859 10.1016/j.ijmm.2008.06.003 1:CAS:528:DC%2BD1MXivVKisr0%3D
28. LP Allsopp M Totsika JJ Tree GC Ulett AN Mabbett TJ Wells B Kobe SA Beatson MA Schembri 2010 UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073 Infect Immun 78 4 1659 1669 20145097 10.1128/IAI.01010-09 1:CAS:528:DC%2BC3cXkt12gtbw%3D
29. P Klemm L Hjerrild M Gjermansen MA Schembri 2004 Structure-function analysis of the self-recognizing Antigen 43 autotransporter protein from Escherichia coli Mol Microbiol 51 283 296 14651628 10.1046/j.1365-2958.2003. 03833.x 1:CAS:528:DC%2BD2cXhs1Wh (Pubitemid 38031088)
30. P Lüthje A Brauner 2010 Putative link between the virulence-associated gene fluA and fluoroquinolone resistance in uropathogenic E. coli J Clin Microbiol 48 675 676 19955281 10.1128/JCM.01443-09
31. J-H Ryu LR Beuchat 2005 Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine Appl Environ Microbiol 71 247 254 15640194 10.1128/AEM.71.1.247-254.2005 1:CAS:528:DC%2BD2MXotlaquw%3D%3D (Pubitemid 40116274)
32. G Uhlich PH Cooke EB Solomon 2006 Analyses of the red-dry-rough phenotype of an Escherichia coli O157:H7 strain and its role in biofilm formation and resistance to antibacterial agents Appl Environ Microbiol 72 2564 2572 16597958 10.1128/AEM.72.4.2564-2572.2006 1:CAS:528:DC%2BD28XktFagur0%3D
33. DI Andersson 2006 The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 9 461 465 16890008 10.1016/j.mib.2006.07.002 1:CAS:528:DC%2BD28XpvFSis7k%3D (Pubitemid 44397630)